Mn Services Vermogensbeheer B.V. decreased its position in shares of The Allstate Co. (NYSE:ALL – Free Report) by 2.4% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 100,373 shares of the insurance provider’s stock after selling 2,500 shares during the quarter. Mn Services Vermogensbeheer B.V.’s holdings in Allstate were worth $19,036,000 as of its most recent SEC filing.
Several other institutional investors have also recently made changes to their positions in the company. BDF Gestion purchased a new position in Allstate in the second quarter valued at $3,051,000. OFI Invest Asset Management acquired a new stake in shares of Allstate during the 2nd quarter valued at about $476,000. Envestnet Portfolio Solutions Inc. grew its position in shares of Allstate by 12.5% during the 1st quarter. Envestnet Portfolio Solutions Inc. now owns 50,383 shares of the insurance provider’s stock valued at $8,717,000 after acquiring an additional 5,586 shares during the period. SG Americas Securities LLC raised its holdings in Allstate by 251.8% in the 1st quarter. SG Americas Securities LLC now owns 53,090 shares of the insurance provider’s stock worth $9,185,000 after purchasing an additional 38,001 shares during the period. Finally, Cetera Investment Advisers boosted its position in Allstate by 351.6% during the first quarter. Cetera Investment Advisers now owns 65,221 shares of the insurance provider’s stock worth $11,284,000 after purchasing an additional 50,780 shares in the last quarter. 76.47% of the stock is owned by hedge funds and other institutional investors.
Allstate Stock Down 1.0 %
Shares of ALL opened at $182.37 on Tuesday. The Allstate Co. has a 52-week low of $127.93 and a 52-week high of $198.79. The company has a quick ratio of 0.36, a current ratio of 0.40 and a debt-to-equity ratio of 0.43. The stock has a fifty day simple moving average of $188.85 and a two-hundred day simple moving average of $175.41. The company has a market capitalization of $48.29 billion, a PE ratio of 11.81, a price-to-earnings-growth ratio of 1.88 and a beta of 0.48.
Insider Buying and Selling
In other news, CEO Thomas J. Wilson sold 90,000 shares of the company’s stock in a transaction on Wednesday, August 21st. The stock was sold at an average price of $179.34, for a total value of $16,140,600.00. Following the transaction, the chief executive officer now owns 88,552 shares of the company’s stock, valued at $15,880,915.68. This represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. In other news, CEO Thomas J. Wilson sold 90,000 shares of the company’s stock in a transaction that occurred on Wednesday, August 21st. The shares were sold at an average price of $179.34, for a total value of $16,140,600.00. Following the transaction, the chief executive officer now directly owns 88,552 shares in the company, valued at approximately $15,880,915.68. This represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, EVP Robert Toohey sold 16,682 shares of the company’s stock in a transaction on Monday, August 19th. The stock was sold at an average price of $180.17, for a total value of $3,005,595.94. Following the transaction, the executive vice president now owns 4,873 shares in the company, valued at $877,968.41. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders sold 192,530 shares of company stock worth $34,967,665. Company insiders own 1.80% of the company’s stock.
Analysts Set New Price Targets
Several brokerages have recently weighed in on ALL. The Goldman Sachs Group upped their target price on Allstate from $199.00 to $204.00 and gave the stock a “buy” rating in a research note on Thursday, August 15th. Keefe, Bruyette & Woods upped their price objective on shares of Allstate from $199.00 to $208.00 and gave the stock an “outperform” rating in a research report on Monday, August 12th. JPMorgan Chase & Co. lifted their target price on shares of Allstate from $205.00 to $207.00 and gave the company an “overweight” rating in a research report on Thursday, October 10th. Wells Fargo & Company reduced their price target on shares of Allstate from $177.00 to $175.00 and set an “equal weight” rating for the company in a research report on Friday, August 16th. Finally, TD Cowen lifted their price objective on Allstate from $193.00 to $224.00 and gave the stock a “buy” rating in a report on Tuesday, September 3rd. One investment analyst has rated the stock with a sell rating, two have given a hold rating, thirteen have issued a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $207.75.
Read Our Latest Research Report on ALL
About Allstate
The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.
Featured Articles
- Five stocks we like better than Allstate
- Airline Stocks – Top Airline Stocks to Buy Now
- Intel: Is Now the Time to Be Brave?
- What is Forex and How Does it Work?
- Carnival or Royal Caribbean—Which Cruise Stock Has More Upside?
- How to Read Stock Charts for Beginners
- Summit Therapeutics: Is Their Lung Cancer Drug a Game Changer?
Want to see what other hedge funds are holding ALL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Allstate Co. (NYSE:ALL – Free Report).
Receive News & Ratings for Allstate Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allstate and related companies with MarketBeat.com's FREE daily email newsletter.